FDA — authorised 27 April 1954
- Application: NDA009321
- Marketing authorisation holder: BRACCO
- Local brand name: CHOLOGRAFIN SODIUM
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Cholografin Meglumine in United States
FDA authorised Cholografin Meglumine on 27 April 1954
Marketing authorisations
FDA
- Status: approved
Cholografin Meglumine in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Gastroenterology approved in United States
Frequently asked questions
Is Cholografin Meglumine approved in United States?
Yes. FDA authorised it on 27 April 1954; FDA has authorised it.
Who is the marketing authorisation holder for Cholografin Meglumine in United States?
BRACCO holds the US marketing authorisation.